News
New Approach to Cancer Immunotherapy Improves Efficacy and Decreases Toxicity College of Science Newsletter, University of Notre Dame (July 9, 2026).
Researchers to Watch in Women’s Health World of Women’s Health, LinkedIn (June 16, 2026).
https://www.linkedin.com/feed/update/urn:li:share:7470158918221066242/
Endometriosis Diagnosis—Reimagined. (April 26, 2026). In collaboration with InterVenn biosciences. All rights reserved.
Expanding endometriosis research: Postdoctoral researcher Ell Handy focuses on women’s health (April 21, 2025).
Unexpected PLOD1 twist Perlara’s Cure Odysseys (2024, January 30).
https://perlara.substack.com/p/unexpected-plod1-twist (credited as L Handy)
The PLOD1 thickens. Perlara’s Cure Odysseys.(2023, April 19).
https://perlara.substack.com/p/the-plod1-thickens(credited as L Handy)
PLOD1-kEDS Cure Roadmap. Perlara’s Cure Odysseys. (2022, June 17).
https://perlara.substack.com/p/plod1-keds-cure-roadmap(credited as L Handy)
Publications
Tumor Immune Cell Targeting Chimeras (TICTACs) reprogram tumor-associated macrophages, Nature Chemical Biology (July 8, 2026)
https://www.nature.com/articles/s41589-026-02258-2
https://www.biorxiv.org/content/10.1101/2023.12.06.570444v2
Synthesis of Biologically Active, Selectively Diversified Iminosugars as Single Enantiomers from 2,4-diene-ols
manuscript under preparation